CRBN-based TRK kinase fusion prot. degrader

degrad. of mult. TRK fusions (e.g. TPM3-TRKA)

from functionalization of lit. TRK inhibitor

J. Med. Chem., Oct. 15, 2020

Cullgen Inc., San Diego, CA / Shanghai, CN

CG428 (Cullgen CRBN-based TRK kinase fusion protein degrader)


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks